the major advances has been the introduction of donor tissue, which has been processed by the distributing eye bank before the scheduled transplant surgery. 1, 2 The major advantage of using precut tissue is that the donor posterior lenticule can be examined and measured immediately after the resection of the anterior cap. Specular microscopy quantifying central endothelial cell density and slit lamp biomicroscopy evaluating tissue quality yield useful information that is available to the surgeon using precut tissue but not available when the surgeon cuts the tissue in the operating room. As a practical matter, using precut tissue should also offer the advantage of decreasing the workload, time, and risk the surgeons, otherwise, experience in preparing the tissue themselves. The disadvantage of precut tissue is that the surgeon passes control of this critical step of surgery to the eye bank technician and does not have the opportunity personally to observe any complications that may have occurred during donor processing. In addition, concerns have been raised as to the possibility of adverse tissue changes that may occur between the now extended time when the tissue is precut and the time it is transplanted. [3] [4] [5] 
PRECUT TISSUE SURVEY
In this issue of Cornea, Kitzmann et al 6 performed a survey of 53 surgeons who received precut tissue for 197 Descemet stripping automated endothelial keratoplasty (DSAEK) surgical procedures. This was not a randomized controlled trial; it was a survey. As such, it was not designed to answer specific questions but merely to give an indication of what is happening out there ''in the real world'' with precut tissue. The authors reported an overall dislocation rate of 23%, an iatrogenic primary graft failure (IPGF) rate of 8%, and a rate of 14% where the recipient cornea failed to clear. The surgeons also reported eccentric trephination of the donor tissue in 3% of cases, with fully 11% of the cases requiring further manipulation of the donor tissue, including manual dissection of the graft edge to achieve their desired diameter of the posterior donor lenticule.
Although the survey indicated that ''novice'' EK surgeons (1-10 cases of experience) had a higher (yet statistically not significantly different) rate of complications than ''experienced'' EK surgeons (.50 cases), it is particularly disturbing that the more experienced surgeons had a dislocation rate of 20% and an IPGF rate of nearly 5%. Even the most experienced surgeons had surgery failure with a 6.7% incidence of the recipient cornea failing to clear. Kitzmann et al compared these results with several published reports by novice surgeons and concluded that the use of precut tissue (in the real world) was no different in its complication rate than the use of tissue prepared by the surgeon. Obviously, without knowledge of what the complication rate would be by this same group of 53 surgeons cutting their own tissue and using their same exact DSAEK surgical technique, a direct comparison of precut with surgeon-cut tissue is not possible in this simple survey, mitigating the certainty of the authors' conclusions.
OUR EXPERIENCE WITH PRECUT TISSUE
Since performing the first US case of EK surgery in Portland, OR, we have continued to modify our EK protocol and surgical technique as this exciting field has matured. 1, [7] [8] [9] [10] We have recently published several articles that report our specific technique, results, and complications with DSAEK surgery. 2, [10] [11] [12] Although not a randomized trial, we now have comparative data between a large consecutive group of DSAEK surgeries for which the tissue was prepared by the surgeon 11 and a large consecutive group of DSAEK surgeries for which the tissue was precut in the eye bank. 2 Importantly, the surgical DSAEK technique we utilized was exactly the same in both surgical series, with the precut versus surgeoncut tissue the only significant variable. With regard to dislocation and IPGF, these 2 groups were comparable. In our first 142 cases of DSAEK with surgeon-cut tissue, the dislocation rate was 1.4%, and the IPGF rate was 0%. 11 In our very first 100 cases of DSAEK using precut tissue, the dislocation rate was 1% and the IPGF rate was 0%. 2 Most importantly, in the precut series at our center, we not only had an experienced surgeon (M.A.T.) performing 65% of the cases but also had 3 completely novice surgeons (0 previous cases of EK) performing 35% of the cases. Our data suggest, therefore, that precut tissue performs at least as well as surgeon-cut tissue for the complications of dislocation and IPGF, regardless of the surgeon's experience level, as long as the specific surgical technique is strictly followed. 2, [10] [11] [12] We have also published the donor characteristics for our precut DSAEK series. 2 We found that regardless of the storage time from death to surgery or the storage time from precutting to surgery, the tissue performed well. Similar to the results of this survey of Kitsmann et al, 6 and contrary to the laboratory studies of Suwan-apichon et al, 3, 4 in our prospective clinical study of 100 consecutive cases using precut tissue, we did not see any abnormal tissue swelling with prolonged donor storage after precutting. Furthermore, we have utilized tissue that was precut even 5 days before surgery without any problems or noticeable differences in tissue morphology or performance.
In over 300 consecutive cases using precut donor tissue, we have experienced only 1 case (our first precut case) in which the donor was eccentrically trephinated. 2, 11 Unlike PK, utilization of the operating microscope is essential when cutting the donor tissue for EK surgery, as EK often requires a tolerance for centration of less than ¼ mm. As described in our publications, the technique of identifying and marking the margins of the microkeratome resection diameter in precut tissue is critical. 2, 11 It is unknown whether the surgeons of this survey who experienced the 3% eccentric cuts personally marked the precut margins or used the microscope for the trephination, but these 2 simple precautions can eliminate this significant complication. Finally, the 11% of cases in this survey that required extension of the diameter of the donor bed with manual dissection are of concern. It would seem less risky for eccentric trephination and also less traumatic to the donor endothelium for the surgeon to simply forgo trying to extend the diameter of the donor tissue bed and simply choose a donor trephine of a smaller size that fits easily into the surgeon measured, precut donor bed. Any perceived gain in demanding a larger donor diameter and increased peripheral endothelial cell numbers are likely severely mitigated by the donor endothelial trauma induced by donor tissue mounting and manual peripheral dissection.
WHY DOES TISSUE STICK AND HOW CAN WE MAKE IT SURVIVE?
Publications by Price and Price 13, 14 and by our group in Portland, OR, 2, 9, 11, 12 have shown a very low rate of dislocation and IPGF in large series of DSAEK cases. Although surgeon's experience is an obvious factor in minimizing complications, at least in our published series, we have shown that even surgeons in training (corneal fellows) can nearly eliminate dislocations and IPGF complications when utilizing a strict surgical technique. 11 At some point, a surgeon who has greater than 50 cases of DSAEK experience, but a higher rate of complications than those reported in the articles of Price or Terry, has got to ask the question: ''Is it still my Ôlearning curveÕ or is it steps in my specific surgical technique that are responsible for my complications?'' Tissue adherence is likely a combination of multiple factors. We have described the primary factors for donor adherence as physical, biochemical, and physiologic in a recent publication. 11 Maximizing the tissue environment in each of these realms should reduce the incidence of dislocation and IPGF.
Improving the physical adhesion of the tissue involves primarily ensuring that no interface fluid remains at the close of surgery. Price and Price 13, 14 have advocated the use of surface sweeping and surface corneal venting incisions to accomplish this goal. We have avoided venting incisions and instead advocated a total air bubble in the anterior chamber with an IOP of 60 mm Hg for 2 minutes of back pressure, which allows simple compressive sweeping of the cornea surface to effectively remove the interface fluid. 2, 9, 11 In addition, we have advocated maximizing the initial physical adhesion of donor tissue by using peripheral recipient bed scraping, effectively increasing surface area for adhesion while keeping the bed diameter the same. 9 Maximizing the physiologic adhesion of the tissue requires protection of the endothelial pump function. Although undoubtedly the more experienced surgeon will be more ''gentle'' with the endothelium during EK surgery, the trauma to the endothelium is also directly related to inherent steps of the surgical technique. 15 We have demonstrated clinically that a 5-mm incision in DLEK surgery results in greater long-term endothelial damage than a 9-mm incision. 8, 16 Our recent vital dye staining studies in DSAEK have similarly shown that reducing the incision size in DSAEK surgery to an even smaller length of 3 mm causes 2-4 times more acute damage to the total endothelium than using a 5-mm incision, regardless of the surgical technique (forceps, Busin or other glide, or ''pull through'') used for insertion. 17, 18 Obviously, regardless of the number of cases performed or the experience of the surgeon, if the technique utilized inherently kills more endothelial cells than another technique, the acute complication rate of IPGF and donor dislocations from this technique will be higher, and the long-term central endothelial cell density will be compromised. As DSAEK surgery techniques evolve, both novice and experienced surgeons need to constantly question each step of their DSAEK procedure to evaluate its effect on donor endothelial health and then, as a priority, make the necessary changes in technique, which favor donor endothelial survival.
The article by Kitsmann et al in this issue of Cornea describes the real world use of precut tissue. This survey raises many questions about the current state of DSAEK surgery. However, I agree with their conclusion that precut tissue is no different in character from tissue that is cut on site by the surgeon at the time of surgery. What remains to be seen, however, is whether individual DSAEK surgical techniques will change and standardize as more surgeons evolve past their ''learning curve,'' and what level of complications surgeons and patients will consider as standard and acceptable.
In this exciting and changing field of EK surgery, one thing is certain: When it comes to minimizing complications, it is the surgical technique, and not the tissue, that counts.
